Discounted Cash Flow (DCF) Analysis Levered
Theradiag SA (ALTER.PA)
1.39 €
-0.01 (0.00%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 8.91 | 9.64 | 10.41 | 11.12 | 12.20 | 13.20 | 14.28 | 15.45 | 16.72 | 18.09 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -1.55 | -1.67 | -1.81 | -1.93 | -2.12 | -2.29 | -2.48 | -2.68 | -2.90 | -3.14 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -0.12 | -0.13 | -0.14 | -0.15 | -0.17 | -0.18 | -0.19 | -0.21 | -0.23 | -0.25 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -1.67 | -1.80 | -1.95 | -2.08 | -2.29 | -2.47 | -2.67 | -2.89 | -3.13 | -3.39 |
Weighted Average Cost Of Capital
| Share price | $ 1.39 |
|---|---|
| Beta | -0.275 |
| Diluted Shares Outstanding | 13.01 |
| Cost of Debt | |
| Tax Rate | 29.64 |
| After-tax Cost of Debt | 3.36% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 2.921 |
| Total Debt | 1.84 |
| Total Equity | 18.08 |
| Total Capital | 19.92 |
| Debt Weighting | 9.23 |
| Equity Weighting | 90.77 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 8.91 | 9.64 | 10.41 | 11.12 | 12.20 | 13.20 | 14.28 | 15.45 | 16.72 | 18.09 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.55 | -1.67 | -1.81 | -1.93 | -2.12 | -2.29 | -2.48 | -2.68 | -2.90 | -3.14 |
| Capital Expenditure | -0.12 | -0.13 | -0.14 | -0.15 | -0.17 | -0.18 | -0.19 | -0.21 | -0.23 | -0.25 |
| Free Cash Flow | -1.67 | -1.80 | -1.95 | -2.08 | -2.29 | -2.47 | -2.67 | -2.89 | -3.13 | -3.39 |
| WACC | ||||||||||
| PV LFCF | -2.40 | -2.52 | -2.65 | -2.79 | -2.93 | |||||
| SUM PV LFCF | -13.29 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 2.96 |
| Free cash flow (t + 1) | -3.45 |
| Terminal Value | -359.82 |
| Present Value of Terminal Value | -310.99 |
Intrinsic Value
| Enterprise Value | -324.27 |
|---|---|
| Net Debt | -4.55 |
| Equity Value | -319.72 |
| Shares Outstanding | 13.01 |
| Equity Value Per Share | -24.58 |